Vaishali Pharma Ltd is a pharmaceutical company engaged in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. They are operating both in domestic and export markets. They have also established an office in Vietnam. At present they are supplying in around 10 countries.
In domestic markets, they are majorly into trading of APIs whereas, in export markets, they are into trading and marketing of APIs, formulations, surgical products and others. Recently they have applied for 186 registrations in 13 countries for some of their products and received 71 approvals from 7 countries.
They export Formulations, Surgical & APIs to Kenya, Sri Lanka, Russia, DR Congo, Myanmar, Tajikistan, Bangladesh, Kazakhstan, Cameroon, Jordan, Burkina -Faso, Nicaragua, Senegal, Pakistan, Ukraine, Yemen, Cambodia, Turkey, Congo, Zimbabwe, Ethiopia, Tanzania, Vietnam, Armenia, Costa Rica, Nigeria, C.A.R. and Guinea-Bissau.
Vaishali Pharma Limited IPO Stock Quote & Charts
- Open: 41.60
- High - Low: 41.60 - 40.00
- Previous Close: 39.75
- Total Traded Volume: 81600
- Updated On: 20-Mar-2019
Objects of the Vaishali Pharma Limited IPO:
1. Working Capital requirements
2. General Corporate Purposes
Vaishali Pharma Limited IPO Details:
| Open Date: |
Aug 07 2017 |
| Close Date: |
Aug 10 2017 |
| Total Shares: |
1,976,000 |
| Face Value: |
₹ 10 Per Equity Share |
| Issue Type: |
Book Built Issue IPO |
| Issue Size: |
14.23 Cr. |
| Lot Size: |
1600 Shares |
| Issue Price: |
₹ 71-72 Per Equity Share |
| Listing At: |
NSE Emerge |
| Listing Date: |
Aug 22 2017 |
Discussion on Vaishali Pharma Limited IPO:
